📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mepolizumab does not alter the blood basophil count in severe asthma. (2019)

First Author: Wright AKA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/all.13879

PubMed Identifier: 31106444

Publication URI: http://europepmc.org/abstract/MED/31106444

Type: Journal Article/Review

Volume: 74

Parent Publication: Allergy

Issue: 12

ISSN: 0105-4538